Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. This Department is a joint venture between the Medical Faculty, Lund University and the Hematology Clinic at Lund University Hospital.
The laboratory investigates the properties of blood stem cells and is developing cell and gene therapy for blood disorders. The development of cell and gene therapy is considered important for many genetic disorders and cancer, disorders that remain incurable at present. Within the laboratory, there are eight independent research groups that collaborate closely to understand the regulation of blood stem cells.
Six of these research groups are members of the Hemato Linné excellence program in blood stem cell biology (Linnaeus Program) funded by The Swedish Research Council and Lund University and several of the groups are also members of STEMTHERAPY, a strategic research and infrastructure program, also supported by The Swedish Research Council.
Professor Hal E Broxmeyer from Indiana University School of Medicine is visiting Lund on June 14-18 and will give a seminar entitled:
”A Potential Global Role for Dipeptidylpeptidase 4 (DPP4/CD26) and its Inhibition in the Regulation of Hematopoiesis and Other Cell Systems”
Time and place: June 17th at 14:00 in Segerfalk lecture hall, BMC A10
This seminar is sponsored by Hemato-Linné and STEMTHERAPY
Welcome to a Minisymposium on "Human Hematopoesis" on June 20, 2013, 13:00 - 16:20 in the Segerfalk lecture hall at BMC A10. We have three invited speakers, Dr Dominique Bonnet, Dr James Mulloy and Dr Claudia Waskow. This minisymposium is arranged by Hemato-Linné and STEMTHERAPY.